Displaying 49 - 60 of 136
Metabolism, Alcohol & Toxicity
6

Medscape Education Global – supported by an Independent educational grant from Madrigal Pharmaceuticals: "Emerging Treatment strategies for NASH: On the road to resolution?" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Medscape Education Global – supported by an Independent educational grant from Madrigal Pharmaceuticals: "Emerging Treatment strategies for NASH: On the road to resolution?" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Medscape Education Global – supported by an Independent educational grant from Madrigal Pharmaceuticals: "Emerging Treatment strategies for NASH: On the road to resolution?" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Medscape Education Global – supported by an Independent educational grant from Madrigal Pharmaceuticals: "Emerging Treatment strategies for NASH: On the road to resolution?" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View